TrialLancet (London, England)2013

Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial.

John R Teerlink et al.PubMed ↗Publisher ↗

No numbers read from the abstract.